Literature DB >> 6872317

Suppression of delayed-type hypersensitivity reactions and lymphokine production by cyclosporin A in the mouse.

A W Thomson, D K Moon, D S Nelson.   

Abstract

Two consecutive daily i.m. injections of cyclosporin A (Cs A) (greater than 50 mg/kg) inhibited delayed type hypersensitivity (DTH) responses in mice immunized with SRBC. Maximal suppression was observed when Cs A was administered 24 and 48 h after sensitization. Culture of spleen cells from these animals with antigen, insoluble concanavalin A (iCon A) or PHA revealed inhibition of the production of two lymphokines: that inducing macrophage procoagulant activity (MPCA) and macrophage chemotactic factor (LDCF). The inhibitory effect on lymphokine production was not due to depletion of T cells. In vitro, 25 ng/ml Cs A suppressed T cell proliferative responses to antigen and mitogen but much higher doses were required to impair the response to LPS. Similar doses of Cs A also suppressed lymphokine production, but the responses of macrophages to these lymphokines was unaffected, even at doses which totally inhibited lymphokine production. Production of interleukin 1 by LPS stimulated macrophages was inhibited by Cs A only at concentrations much greater than those required to suppress lymphokine production.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6872317      PMCID: PMC1536020     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  33 in total

1.  Cyclosporin A: an immunosuppressive agent preferentially active against proliferating T cells.

Authors:  D J White; A M Plumb; G Pawelec; G Brons
Journal:  Transplantation       Date:  1979-01       Impact factor: 4.939

2.  Nature of the unresponsiveness induced by cyclosporin A in rats bearing renal allografts.

Authors:  W P Homan; J W Fabre; P J Morris
Journal:  Transplantation       Date:  1979-11       Impact factor: 4.939

3.  Use of cyclosporin A in allogeneic bone marrow transplantation in the rat.

Authors:  P J Tutschka; W E Beschorner; A C Allison; W H Burns; G W Santos
Journal:  Nature       Date:  1979-07-12       Impact factor: 49.962

4.  A mechanism of migration inhibition in delayed-type hypersensitivity reactions. I. Fibrin deposition on the surface of elicited peritoneal macrophages on vivo.

Authors:  K E Hopper; C L Geczy; W A Davies
Journal:  J Immunol       Date:  1981-03       Impact factor: 5.422

5.  Timing of cyclosporin-A therapy for abrogation of HVG and GVH responses in rats.

Authors:  J R Markwick; J D Chambers; J R Hobbs; G D Pegrum
Journal:  Lancet       Date:  1979-11-17       Impact factor: 79.321

6.  Effects of in vivo treatments with cyclosporin-A on mouse cell-mediated immune responses.

Authors:  S Alberti; D Boraschi; W Luini; A Tagliabue
Journal:  Int J Immunopharmacol       Date:  1981

7.  Cyclosporin A in cadaveric organ transplantation.

Authors:  R Y Calne; D J White; D B Evans; S Thiru; R G Henderson; D V Hamilton; K Rolles; P McMaster; T J Duffy; B R MacDougall; R Williams
Journal:  Br Med J (Clin Res Ed)       Date:  1981-03-21

8.  Extensive prolongation of rabbit kidney allograft survival after short-term cyclosporin-A treatment.

Authors:  C J Green; A C Allison
Journal:  Lancet       Date:  1978-06-03       Impact factor: 79.321

9.  Cyclosporin a. Inhibition of experimental autoimmune uveitis in Lewis rats.

Authors:  R B Nussenblatt; M M Rodrigues; W B Wacker; S J Cevario; M C Salinas-Carmona; I Gery
Journal:  J Clin Invest       Date:  1981-04       Impact factor: 14.808

10.  Cyclosporin A mediates immunosuppression of primary cytotoxic T cell responses by impairing the release of interleukin 1 and interleukin 2.

Authors:  D Bunjes; C Hardt; M Röllinghoff; H Wagner
Journal:  Eur J Immunol       Date:  1981-08       Impact factor: 5.532

View more
  13 in total

1.  T-cell-independent macrophage activation in mice induced with rRNA from Listeria monocytogenes and dimethyldioctadecylammonium bromide.

Authors:  J F van den Bosch; I Y Kanis; A C Antonissen; W A Buurman; C P van Boven
Journal:  Infect Immun       Date:  1986-09       Impact factor: 3.441

2.  Effect of anticancer drugs on the release of interferon gamma in vitro.

Authors:  K Ahmed; P H van der Meide; J L Turk
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

3.  Topical cyclosporin A in nickel contact hypersensitivity: results of a preliminary clinical and immunohistochemical investigation.

Authors:  R D Aldridge; H F Sewell; G King; A W Thomson
Journal:  Clin Exp Immunol       Date:  1986-12       Impact factor: 4.330

Review 4.  The influence of cyclosporin A on cell-mediated immunity.

Authors:  A W Thomson; L M Webster
Journal:  Clin Exp Immunol       Date:  1988-03       Impact factor: 4.330

5.  Effect of cyclosporin A on autoimmune tubulointerstitial nephritis in the brown Norway rat.

Authors:  A Giménez; F Leyva-Cobián; C Fierro; M Río; T Bricio; F Mampaso
Journal:  Clin Exp Immunol       Date:  1987-09       Impact factor: 4.330

6.  Antigen presentation and HLA-DR expression by FK-506-treated human monocytes.

Authors:  J Woo; D J Propper; A W Thomson
Journal:  Immunology       Date:  1990-12       Impact factor: 7.397

7.  Renal and hepatic function in rats treated with cyclosporin A in combination with gentamicin or cephalosporin antibiotics.

Authors:  P H Whiting; A W Thomson; J G Simpson
Journal:  Br J Exp Pathol       Date:  1983-12

8.  The effect of cyclosporine on immunization with tetanus and keyhole limpet hemocyanin (KLH) in humans.

Authors:  A G Palestine; F Roberge; B L Charous; H C Lane; A S Fauci; R B Nussenblatt
Journal:  J Clin Immunol       Date:  1985-03       Impact factor: 8.317

9.  Effects of cyclosporin A on humoral immunity to ticks and on cutaneous immediate and delayed hypersensitivity reactions to Ixodes ricinus L. salivary-gland antigens in re-infested rabbits.

Authors:  P Girardin; M Brossard
Journal:  Parasitol Res       Date:  1989       Impact factor: 2.289

10.  Effect of anticancer drugs on the release of tumour necrosis factor in vitro.

Authors:  S I Hasan; K Ahmed; J L Turk
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.